MetaCap

MBX Biosciences (MBX) News

NASDAQ: MBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

49.55-3.86 (-7.23%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

MBX news summary

We found 3 recent headlines mentioning MBX Biosciences (MBX): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire, Seeking Alpha. MBX is making an outsized move today, down 7.23% at $49.55, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "MBX Biosciences GAAP EPS of -$1.29", was published by Seeking Alpha on Nov 9, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest MBX Biosciences headlines

Compare MBX